SkinBioTherapeutics plc (AIM:SBTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
22.00
-0.75 (-3.30%)
May 6, 2025, 1:12 PM GMT+1

SkinBioTherapeutics Revenue

SkinBioTherapeutics had revenue of 1.58M GBP in the half year ending December 31, 2024, with 1,947.84% growth. This brings the company's revenue in the last twelve months to 2.68M, up 1,557.07% year-over-year. In the fiscal year ending June 30, 2024, SkinBioTherapeutics had annual revenue of 1.21M with 815.26% growth.

Revenue (ttm)
2.68M
Revenue Growth
+1,557.07%
P/S Ratio
19.79
Revenue / Employee
178.57K
Employees
15
Market Cap
53.00M

Revenue Chart

Created with Highcharts 11.4.8SkinBioTherapeutics Revenue - Annual74.76K74.76K132.06K132.06K1.21M1.21M20202021202220232024-250K500K750K1M1M

History

Fiscal Year End Revenue Change Growth
Jun 30, 20241.21M1.08M815.26%
Jun 30, 2023132.06K57.30K76.64%
Jun 30, 202274.76K--
Jun 30, 2021---
Jun 30, 2020---
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings